EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 91 filers reported holding EIDOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $997,000 | +136.3% | 20,911 | +142.8% | 0.01% | +100.0% |
Q1 2020 | $422,000 | -58.0% | 8,612 | -50.8% | 0.00% | -55.6% |
Q4 2019 | $1,005,000 | -30.8% | 17,509 | -56.6% | 0.01% | -25.0% |
Q3 2019 | $1,452,000 | +1061.6% | 40,357 | +903.4% | 0.01% | +1100.0% |
Q2 2019 | $125,000 | – | 4,022 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |